Accession Number: | 0001209191-19-013904 |
Date: | 2019-02-24 |
Issuer: | OVID THERAPEUTICS INC. (OVID) |
Original Submission Date: |
DURING MATTHEW
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044
NEW YORK, NY 10036
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 1.89 | 2019-02-24 | deemed execution date | A | 70,000 (a) | 2029-02-23 | common stock 70,000 | $1.89 | 70,000 | direct |
ID | footnote |
---|---|
f1 | 25% of the shares subject to the stock option will vest and become exercisable on february 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the reporting person's continued services through such date. |